St. Jude Confident In 2013 Growth Plan Despite Market Challenges
This article was originally published in The Gray Sheet
Executive Summary
Anticipated growth drivers include the firm’s MediGuide catheter tracking system, EnligHTN multi-electrode renal denervation system and Portico transcatheter aortic valve, aided by a return to stability of the cardiac rhythm management market by the first half of 2013.
You may also be interested in...
St. Jude Outlines Strategy To Revive Pacemaker Business
St. Jude Medical’s pacemaker revenue dropped 12 percent year-over-year in the first quarter, but the firm says it has several products in the pipeline that could help it regain pacemaker market share in Europe and Japan.
Challenges With ICD Leads Are Under Control, St. Jude Tells Investors
The company was prepared for FDA’s recent warning letter, executives said on an earnings call. But the scrutiny is not over, analysts suggest.
News In Brief
McKesson buys PSS World Medical. St. Jude Medical draws FDA form 483. Cibiem raises $10 million for heart failure, hypertension treatment. More news briefs.